CompletedNCT02268734

Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib

Studying Medullary thyroid carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Principal Investigator
Laura Locati, MD
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Enrollment
36 target
Eligibility
18 years · All sexes
Timeline
2014 – 2018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02268734 on ClinicalTrials.gov

Other trials for Medullary thyroid carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Medullary thyroid carcinoma →

← Back to all trials